Free Newsletter
Register for our Free Newsletters
Newsletter
Zones
Advanced Composites
LeftNav
Aerospace
LeftNav
Amorphous Metal Structures
LeftNav
Analysis and Simulation
LeftNav
Asbestos and Substitutes
LeftNav
Associations, Research Organisations and Universities
LeftNav
Automation Equipment
LeftNav
Automotive
LeftNav
Biomaterials
LeftNav
Building Materials
LeftNav
Bulk Handling and Storage
LeftNav
CFCs and Substitutes
LeftNav
Company
LeftNav
Components
LeftNav
Consultancy
LeftNav
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Manufacturing Zone
Pro Security Zone
Web Lec
Pro Engineering Zone
 
 
 
News

Findings point way to identifying therapeutics to stem muscle atrophy

Boston University : 16 November, 2004  (Technical Article)
In research that could benefit astronauts posted to the International Space Station as well as individuals whose universe is defined by their sick bed, Boston University Sargent College researchers Susan Kandarian and R. Bridge Hunter have found that disrupting either one of two genes, nfκb1 and bcl3, can block the biological process of muscle wasting known as atrophy.
Their findings will inform efforts to identify therapeutics that could inhibit muscle atrophy caused by a chronic reduction in muscle use. Such treatments could end the muscle loss, weakness, and fatigue that can plague space travelers, sedentary or bed-ridden individuals, or anyone whose muscles undergo long periods of disuse.

“By understanding the genes necessary for muscle atrophy,” says Kandarian, lead researcher and professor of health sciences at BU Sargent College of Health and Rehabilitation Sciences, “we can begin to study the protein products required for atrophy. Our ongoing research shows that the process of atrophy might be partially moderated by something as straightforward as aspirin or other non-steroidal anti-inflammatory drugs.”

It is well known that prolonged muscle disuse causes muscles to lose protein in two ways: by decreasing the amount of protein synthesized and by increasing the rate at which muscle protein is degraded. The intracellular signals that drive muscle protein to these extremes, however, are not well known.

When designing her study, Kandarian chose to investigate the role of nfκb1 and bcl3, two gene members from a family of transcription factors, genes that produce proteins that regulate the activities of other genes. Her previous research had shown these transcriptional regulators were implicated in the process of muscle atrophy.

By studying strains of mice bred to be without the nfκb1 gene or without the bcl3 gene, so-called knockout mice, and then comparing knockout results with those from control groups as well as those from genetically unaltered (“wild-type”) mice, Kandarian was able to isolate the effects either gene had on triggering atrophy in each of two weight-bearing muscles in the mouse hind limb: the soleus, a so-called slow-fast muscle, and the plantaris, a fast muscle. The differing muscle fiber make-up allowed Kandarian to assess what changes in the muscle’s phenotype were linked to the atrophy process. A slow-to-fast change in phenotype is typical in muscle atrophy.

After 10 days of reduced weight-bearing use, all groups of mice were assessed for changes in muscle fiber size, fiber phenotype, and activation of an injected NF-κB reporter gene. This reporter gene reflects the muscles’ transcriptional activity of the two genes the scientists were studying. Kandarian found that when muscle fiber size of the soleus in knockouts and wild types were compared, knockout mice showed virtually no changes after the long period of disuse. Plantaris muscle fiber size in knockout mice also showed very little atrophy compared to wild type; fiber atrophy was inhibited by 67 percent.

Kandarian also found an absence of a slow-to-fast shift in phenotype in the knockout groups, a shift that remained in the wild type mice, and an absence of NF-κB reporter activity in the muscles of the knockout mice. In comparison, wild type muscles subjected to disuse show a sevenfold increase in NF-κB reporter activity.

The researchers conclude that atrophy associated with prolonged muscular inactivity requires the involvement of nfκb1 and bcl3. Their findings are reported in the latest issue of The Journal of Clinical Investigation. The work was supported by grants from the National Space Biomedical Research Institute and the National Institute of Arthritis and Musculoskeletal and Skin Diseases.
Bookmark and Share
 
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
 
   Â© 2012 NewMaterials.com
Netgains Logo